| Application no. and date | 22843301.7 (espacenet) (Federated) (European Patent Register), 20221221 | | Patent/reg. no. and date | DK/EP 4452412, 20251029 | | Publication date | 20241030 | | Priority no. and date | EP 21217179, 20211222 | | EP pub. no. and date |
EP 4452412 20241030 | | Effective date | | | Applicant/owner | BioVersys AG, Hochbergerstrasse 60c
4057 Basel, CH | | Applicant ref. no. | | | Inventor | LOCIURO, Sergio,
4058 Basel, CH,
GITZINGER, Marc,
4057 Basel, CH,
ANTRAYGUES, Kevin,
59120 Loos, FR,
BOUROTTE, Marilyne,
59840 Perenchies, FR,
DALE, Glenn E.,
4053 Basel, CH,
DEFERT, Olivier,
59000 Lille, FR,
MAINGOT, Mathieu,
59800 Lille, FR,
TREBOSC, Vincent,
68680 Kembs-Loechlé, FR,
WILLAND, Nicolas,
59800 Lille, FR | | Representative | | | Opponent | | | IPC Class | A61K 31/445 (2006.01) , A61P 31/04 (2006.01) , C07D 498/22 (2006.01) | | Title | RIFABUTIN ANALOGS FOR THE TREATMENT OF DISEASE | | Int. application no. | EP2022087273 | | Int. publication no. | WO2023118319 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
